痊癒者血漿救了十一人!
https://tw.news.yahoo.com/武漢肺炎-中國用痊癒者血漿分離免疫球蛋白-治療11名重症病患效果顯著-001700378.html

Yahoo is now a part of Verizon Media

Yahoo is part of Verizon Media. Verizon Media and our partners need your consent to access your device and use your data (including location) to understand your interests, and provide and measure pers

https://tw.news.yahoo.com/%E6%AD%A6%E6%BC%A2%E8%82%BA%E7%82%8E-%E4%B8%AD%E5%9C%8B%E7%94%A8%E7%97%8A%E7%99%92%E8%80%85%E8%A1%80%E6%BC%BF%E5%88%86%E9%9B%A2%E5%85%8D%E7%96%AB%E7%90%83%E8%9B%8B%E7%99%BD-%E6%B2%BB%E7%99%8211%E5%90%8D%E9%87%8D%E7%97%87%E7%97%85%E6%82%A3%E6%95%88%E6%9E%9C%E9%A1%AF%E8%91%97-001700378.html
Past 31 days
Total Visit: 0
There is 1 fact-checking reply to the message
Asdfgh mark this message contains personal perspective
originally written by Asdfgh
中科院上海巴斯德研究所解釋,血液主要成分包括血細胞和血漿,血漿去除纖維蛋白原之後即為血清。血清療法早在100多年前就被科學家用來對抗傳染病,但可行性要看實際情況。而且血清成分複雜,對於是否會引起其他問題還存在不確定性。

Opinion Sources

https://www.storm.mg/article/2291747

武漢肺炎風暴》康復者血漿真的是「救命良藥」?專家解讀10個關鍵問題-風傳媒

中國武漢肺炎(新型冠狀病毒肺炎)疫情作戰進入關鍵時刻,13日晚間舉行的湖北省疫情防控記者會上,武漢金銀潭醫院院長張定宇表示,醫院正在開展康復病人恢復期血漿的輸入,目前已顯示初步效果,康復患者體內有大量綜合抗體對抗病毒。 中國國藥集團旗下中國生物技術公司(中國生物)13日也發布消息稱,已完成對部分康復者血漿的採集工作,製備新冠病毒特免血漿製品和特免球蛋白,從8日開始在武漢市江夏區第一人民醫院進行治

https://www.storm.mg/article/2291747

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.

Add Cofacts as friend in LINE
Add Cofacts as friend in LINE
LINE 機器人
查謠言詐騙